Award Date
1-1-2001
Degree Type
Thesis
Degree Name
Master of Science (MS)
Department
Kinesiology
First Committee Member
Lawrence Golding
Number of Pages
111
Abstract
Most governing sports authorities have banned the use of anabolic steroids as ergogenic aids. Recently, a transdermal testosterone precursor dietary supplement (AndrosteDERMRTM) has become available; athletes can apply the cream to their skin with the belief that it will increase serum testosterone levels, muscle mass, and strength. The purpose of this study was to measure the effects of one milliliter of AndrosteDERMRTM) applied to the inner surface of the upper arm on the serum levels of androstenedione, and free and total testosterone in female subjects. Serum levels were measured before application and every 45 minutes thereafter for six hours. Serum androstenedione, and free and total testosterone levels were analyzed using radioimmunoassay. Although the trend seemed to indicate that serum levels did not rise after application, several subjects had physiologically impossible values, which appear to be due to methodological errors. That information, along with the initial small number of subjects made the use of statistical treatment unwise and inferences about the population impossible.
Keywords
Acute; Administration; Effects; Females; Hormone; Levels; Precursors; Serum; Steroid; Testosterone; Transdermal
Controlled Subject
Pharmacology; Nutrition
File Format
File Size
2508.8 KB
Degree Grantor
University of Nevada, Las Vegas
Language
English
Permissions
If you are the rightful copyright holder of this dissertation or thesis and wish to have the full text removed from Digital Scholarship@UNLV, please submit a request to digitalscholarship@unlv.edu and include clear identification of the work, preferably with URL.
Repository Citation
Rasmussen, Mark Anthony, "The acute effects of transdermal testosterone precursor administration on serum steroid hormone levels in females" (2001). UNLV Retrospective Theses & Dissertations. 1296.
http://dx.doi.org/10.25669/tl8e-hgpi
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/
COinS